Merck Patent GmbH;Cancer Research Technology Limited
发明人:
Kai Schiemann,Frank Stieber,Christina Esdar
申请号：
US14375072
公开号：
US09493444B2
申请日:
2013.01.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention provides novel substituted azaheterocyclic compounds according to Formula (I),their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
